1. A Systematic Review of Phase II Targeted Therapy Clinical Trials in Anaplastic Thyroid Cancer
   Josip Ljubas et al, 2019, Cancers CrossRef
2. Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
   Hyeok Jun Yun et al, 2022, International Journal of Molecular Sciences CrossRef
3. Inhibition ofHAX-1by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells
   Jiajia Liu et al, 2016, Oncotarget CrossRef
4. Recent advances in precision medicine for the treatment of anaplastic thyroid cancer
   Silvia Martina Ferrari et al, 2019, Expert Review of Precision Medicine and Drug Development CrossRef
5. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis
   Liqi Li et al, 2020, Technology in Cancer Research & Treatment CrossRef
6. Novel treatment options for anaplastic thyroid cancer
   Poupak Fallahi et al, 2017, Expert Review of Endocrinology & Metabolism CrossRef
7. Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines
   Mika Shimamura et al, 2017, Endocrine CrossRef
8. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers
   Tara Jarboe et al, 2021, Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions CrossRef
9. Recent Development of Nuclear Molecular Imaging in Thyroid Cancer
   Huiting Liu et al, 2018, BioMed Research International CrossRef
10. Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers
    Mi-Hyeon You et al, 2021, Cells CrossRef
11. Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy‐lysosome mediated OCT4A degradation
    Liying Wu et al, 2022, Phytotherapy Research CrossRef
12. Advances in small molecule therapy for treating metastatic thyroid cancer
    Jolanta Krajewska et al, 2017, Expert Opinion on Pharmacotherapy CrossRef
13. Diallyl trisulphide, a H2S donor, compromises the stem cell phenotype and restores thyroid‐specific gene expression in anaplastic thyroid carcinoma cells by targeting AKT‐SOX2 axis
    Li Zhang et al, 2021, Phytotherapy Research CrossRef
14. Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer
    Anna C. Beck et al, 2022, Surgery CrossRef
15. Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
    Seok-Mo Kim et al, 2020, Cancers CrossRef
16. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells
    Mehmet A. Kocdor et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
17. Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways
    Cheolwon Choi et al, 2018, Oncogenesis CrossRef
18. Types of Cancer Stem Cells
    Gautham Chengizkhan et al, 2020, Cancer Stem Cells: New Horizons in Cancer Therapies CrossRef